THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW)

Nargiza Mirshovkatovna NORMATOVA; Firdavs Faridovich KHAMIDULLAEV; Temur Tolibovich SAIDOV

THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW)

Authors

Nargiza Mirshovkatovna NORMATOVA D. in Medicine, Associate Professor at the Centre for Development of Professional Qualification of Medical Workers
Firdavs Faridovich KHAMIDULLAEV Assistant-trainee of postgraduate course in Ophthalmology Samarkand State Medical University
Temur Tolibovich SAIDOV Head of postgraduate course in ophthalmology Samarkand State Medical University

Keywords:

Angiogenesis Inhibitors, VGEF, DME, DM

Abstract

This article discusses treatments with angiogenesis inhibitors in the complex treatment of diabetic macular edema. A comparative analysis of all types of anti-VGEF drugs on macular edema is given. The use of brolucizumab is described in detail as the most optimal method among anti-VGEF drugs for the management of macular edema. It also provides the latest data with clinically confirmed data on the use of this drug.

Downloads

Published

2022-05-17

How to Cite

Nargiza Mirshovkatovna NORMATOVA, Firdavs Faridovich KHAMIDULLAEV, & Temur Tolibovich SAIDOV. (2022). THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW). World Bulletin of Public Health, 10, 81-84. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/959